Towards a targeted, risk-based, antifungal strategy in neutropenic patients.
Prentice
H G
HG
Department of Haematology, Royal Free and University College Medical School, Royal Free Campus and Hospital, London, UK. prentice@rfhsm.ac.uk
Kibbler
C C
CC
Prentice
A G
AG
D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D016470:Bacteremia / Q000150:complications; D016026:Bone Marrow Transplantation; D005938:Glucocorticoids / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000150:complications; D006801:Humans; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control*; D009503:Neutropenia / Q000209:etiology*; D009894:Opportunistic Infections / Q000517:prevention & control; D018579:Patient Selection; D012307:Risk Factors; D012720:Severity of Illness Index
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids